ArticleJournal of virology2026
Novel African
Yueying Zhang, Shigeru Fujita, Masahiro Kajihara, Katendi Changula, Bernard Mudenda Hang'ombe, Shusuke Kawakubo, Spyros Lytras, Jumpei Ito, Akinori Kanai, Yutaka Suzuki and 2 more
Abstract read
In one paragraphArticle in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Yueying ZhangDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0009-0007-2246-8172 Shigeru FujitaDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0001-9008-2123 Masahiro KajiharaDivision of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Katendi ChangulaDepartment of Para-Clinical Studies, School of Veterinary Medicine, the University of Zambia, Lusaka, Zambia.
Bernard Mudenda Hang'ombeDepartment of Para-Clinical Studies, School of Veterinary Medicine, the University of Zambia, Lusaka, Zambia.
Shusuke KawakuboDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Spyros LytrasDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Jumpei ItoDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Akinori KanaiLife Science Data Research Center, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
Yutaka SuzukiLife Science Data Research Center, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
Kei SatoDivision of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0003-4431-1380 Funding
AIST KAKUSEI projectJapan Agency for Medical Research and Development 26jf0126002, 263fa727002, 26wm0225041, 24fk0108907, JP26fk0108690Japan Agency for Medical Research and Development JP20wm0125008Japan Agency for Medical Research and Development JP223fa627001Japan Science and Technology Agency JPMJPR22R1Japan Society for the Promotion of Science 120259601, JP23K20041, JP24H00607Japan Society for the Promotion of Science 24KJ0628Japan Society for the Promotion of Science JP25K00116Mitsubishi UFJ Financial Group, Inc. Vaccine Development GrantSHIONOGI Infectious Disease Research Promotion FoundationThe Cooperative Research Program (Joint Usage/Research Center program) of Institute for Life and Medical Sciences, Kyoto University
6 · The paper itselfAbstract
Sarbecoviruses, including SARS-CoV and SARS-CoV-2, are frequently linked to IMPORTANCE: As putative natural reservoirs of sarbecoviruses, including SARS-CoV and SARS-CoV-2, Rhinolophus bats play a critical role in the emergence of zoonotic coronaviruses, making it essential to understand their interactions with these viruses for future pandemic preparedness. While Asian
Indexed as
Angiotensin-Converting Enzyme 2ChiropteraPeptidyl-Dipeptidase AVirus InternalizationAmino Acid SequenceAnimalsHumansLungPhylogenyReceptors, VirusSARS-CoV-2Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase AReceptors, VirusSpike Glycoprotein, CoronavirusACE2coronavirushorseshoe batssarbecovirusSARS-CoV-2spillover
Identifiers
PMID42627230
PMCPMC13595973
What OpenQuestion holds
Textmetadata
Read underepoch 390